Ronald D’Amico

2.4k total citations
70 papers, 942 citations indexed

About

Ronald D’Amico is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ronald D’Amico has authored 70 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 32 papers in Virology and 17 papers in Epidemiology. Recurrent topics in Ronald D’Amico's work include HIV/AIDS drug development and treatment (36 papers), HIV Research and Treatment (32 papers) and HIV/AIDS Research and Interventions (23 papers). Ronald D’Amico is often cited by papers focused on HIV/AIDS drug development and treatment (36 papers), HIV Research and Treatment (32 papers) and HIV/AIDS Research and Interventions (23 papers). Ronald D’Amico collaborates with scholars based in United States, United Kingdom and Belgium. Ronald D’Amico's co-authors include H. Hank Simms, William Spreen, Susan L. Ford, Parul Patel, Donna Mildvan, David A. Margolis, Rodica Van Solingen‐Ristea, Herta Crauwels, Ralph Zalusky and Amy Cutrell and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Ronald D’Amico

69 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald D’Amico United States 19 528 364 238 156 139 70 942
Peter Gute Germany 18 868 1.6× 688 1.9× 308 1.3× 56 0.4× 216 1.6× 35 1.2k
Hamid Hasson Italy 13 468 0.9× 345 0.9× 224 0.9× 65 0.4× 142 1.0× 69 792
A. Loy Italy 11 272 0.5× 183 0.5× 150 0.6× 94 0.6× 117 0.8× 21 584
George Perez United States 15 413 0.8× 169 0.5× 353 1.5× 59 0.4× 143 1.0× 36 785
Kunihisa Tsukada Japan 18 507 1.0× 109 0.3× 357 1.5× 204 1.3× 216 1.6× 56 991
Antonio Chirianni Italy 17 553 1.0× 429 1.2× 292 1.2× 80 0.5× 444 3.2× 70 1.1k
Frank D. Goebel Germany 12 684 1.3× 671 1.8× 196 0.8× 122 0.8× 515 3.7× 30 1.2k
J Falloon United States 7 454 0.9× 508 1.4× 400 1.7× 75 0.5× 430 3.1× 9 1.1k
Claudia Martorell United States 14 467 0.9× 217 0.6× 598 2.5× 75 0.5× 155 1.1× 28 1.3k
J Beylot France 18 321 0.6× 137 0.4× 239 1.0× 91 0.6× 145 1.0× 98 984

Countries citing papers authored by Ronald D’Amico

Since Specialization
Citations

This map shows the geographic impact of Ronald D’Amico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald D’Amico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald D’Amico more than expected).

Fields of papers citing papers by Ronald D’Amico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald D’Amico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald D’Amico. The network helps show where Ronald D’Amico may publish in the future.

Co-authorship network of co-authors of Ronald D’Amico

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald D’Amico. A scholar is included among the top collaborators of Ronald D’Amico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald D’Amico. Ronald D’Amico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
D’Amico, Ronald, Kelong Han, Sherene Min, et al.. (2025). Subcutaneous injections of cabotegravir plus rilpivirine long-acting in virally suppressed adults with HIV-1. AIDS. 39(15). 2182–2190. 1 indexed citations
3.
4.
Tan, Darrell H. S., Clifford Kinder, Cornelius N. Van Dam, et al.. (2024). Weight and Metabolic Changes With Long-Acting Cabotegravir and Rilpivirine or Bictegravir/Emtricitabine/Tenofovir Alafenamide. JAIDS Journal of Acquired Immune Deficiency Syndromes. 98(4). 401–409. 4 indexed citations
5.
Polli, Joseph W., Parul Patel, Richard Grove, et al.. (2023). Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials. The Journal of Infectious Diseases. 230(1). e34–e42. 10 indexed citations
6.
Oka, Shinichi, Takuma Shirasaka, Jun Yong Choi, et al.. (2023). Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96. HIV Medicine. 25(3). 381–390. 1 indexed citations
7.
Karver, Tahilin Sanchez, Alessandro Berni, Antonella Castagna, et al.. (2023). Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial. AIDS Patient Care and STDs. 37(1). 53–59. 5 indexed citations
8.
9.
10.
D’Amico, Ronald, et al.. (2006). Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive multifocal leukoencephalopathy. Scandinavian Journal of Infectious Diseases. 39(4). 347–350. 16 indexed citations
11.
D’Amico, Ronald & Ralph Zalusky. (2005). A case of lues maligna in a patient with acquired immunodeficiency syndrome (AIDS). Scandinavian Journal of Infectious Diseases. 37(9). 697–700. 20 indexed citations
12.
Al‐Harthi, Lena, John C. Voris, Simone Becker, et al.. (2004). Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients. HIV Medicine. 5(1). 55–65. 31 indexed citations
13.
Simms, H. Hank, Ronald D’Amico, & Kirby I. Bland. (1997). Integrin Stimulation Regulates Polymorphonuclear Leukocytes Inflammatory Cytokine Expression. Annals of Surgery. 225(6). 757–765. 10 indexed citations
14.
Simms, H. Hank & Ronald D’Amico. (1997). STUDIES ON POLYMORPHONUCLEAR LEUKOCYTE BACTERICIDAL FUNCTION. Shock. 7(2). 84–89. 13 indexed citations
15.
Graeber, Thomas G., et al.. (1996). Altered Oxygen Tension Modulates Cytokine-Induced Signal Transduction in Polymorphonuclear Leukocytes: Regulation of the GPLCPathway. Journal of Surgical Research. 62(1). 32–40. 6 indexed citations
16.
Simms, H. Hank & Ronald D’Amico. (1995). Subcellular Location of Neutrophil Opsonic Receptors Is Altered by Exogenous Reactive Oxygen Species. Cellular Immunology. 166(1). 71–82. 12 indexed citations
17.
Simms, H. Hank & Ronald D’Amico. (1995). Regulation of polymorphonuclear neutrophil CD16 and CD11b/CD18 expression by matrix proteins during hypoxia is VLA-5, VLA-6 dependent. The Journal of Immunology. 155(10). 4979–4990. 18 indexed citations
18.
D’Amico, Ronald, et al.. (1992). Intra-abdominal sepsis alters tumor necrosis factor-α and interleukin-1β binding to human neutrophils. Critical Care Medicine. 20(1). 11–16. 6 indexed citations
19.
Simms, H. Hank & Ronald D’Amico. (1992). Endotoxin suppresses matrix protein-induced upregulation of PMN candicidal activity: An effect reversed by low-dose TNF-α. Journal of Surgical Research. 52(5). 489–498. 3 indexed citations
20.
Simms, H. Hank & Ronald D’Amico. (1991). Increased PMN CD11b/CD18 expression following post-traumatic ARDS. Journal of Surgical Research. 50(4). 362–367. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Gute Breakdown of academic impact, for papers by Hamid Hasson Breakdown of academic impact, for papers by A. Loy Breakdown of academic impact, for papers by George Perez Breakdown of academic impact, for papers by Kunihisa Tsukada Breakdown of academic impact, for papers by Antonio Chirianni Breakdown of academic impact, for papers by Frank D. Goebel Breakdown of academic impact, for papers by J Falloon Breakdown of academic impact, for papers by Claudia Martorell Breakdown of academic impact, for papers by J Beylot
Rankless by CCL
2026